BE680696A - - Google Patents
Info
- Publication number
- BE680696A BE680696A BE680696A BE680696A BE680696A BE 680696 A BE680696 A BE 680696A BE 680696 A BE680696 A BE 680696A BE 680696 A BE680696 A BE 680696A BE 680696 A BE680696 A BE 680696A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Connector Housings Or Holding Contact Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEC0035799 | 1965-05-08 | ||
| DEC0037133 | 1965-10-12 | ||
| DEC0037142 | 1965-10-13 | ||
| AT934165A AT260240B (de) | 1965-10-15 | 1965-10-15 | Verfahren zur Herstellung von neuen Dikarbonsäureimidderivaten, sowie Salzen dieser Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE680696A true BE680696A (cs) | 1966-11-07 |
Family
ID=27422273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE680696A BE680696A (cs) | 1965-05-08 | 1966-05-06 |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE680696A (cs) |
| CH (1) | CH478117A (cs) |
| FR (2) | FR1592059A (cs) |
| GB (1) | GB1075420A (cs) |
| IL (1) | IL25595A (cs) |
| NO (1) | NO123088B (cs) |
| OA (1) | OA01951A (cs) |
| PH (1) | PH10158A (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581396A (en) * | 1968-09-18 | 1986-04-08 | Raychem Corporation | Flame retardants and compositions containing them |
| US4644066A (en) * | 1968-09-18 | 1987-02-17 | Raychem Corporation | Flame retardants and compositions containing them |
| US4535170A (en) * | 1968-09-18 | 1985-08-13 | Raychem Corporation | Flame retardants and compositions containing them |
| US4374220A (en) | 1968-09-18 | 1983-02-15 | Raychem Corporation | Imide flame retardants and compositions containing them |
| DE2003608A1 (de) * | 1970-01-28 | 1971-08-05 | Gruenenthal Chemie | Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung |
| EP1064277B1 (en) * | 1998-03-16 | 2005-06-15 | Celgene Corporation | 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| US7320991B2 (en) | 2001-02-27 | 2008-01-22 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health | Analogs of thalidomide as potential angiogenesis inhibitors |
| ES2172474B1 (es) * | 2001-03-01 | 2004-01-16 | Fundacion Universitaria San Pa | Derivados de glutarimida como agentes terapeuticos. |
| WO2005016326A2 (en) * | 2003-07-11 | 2005-02-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Analogs of thalidomide as potential angiogenesis inhibitors |
| CA2808646C (en) | 2003-09-17 | 2016-08-23 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Thalidomide analogs as tnf-alpha modulators |
| US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
| CA2648216C (en) | 2006-04-13 | 2016-06-07 | Michael Gutschow | Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
-
1966
- 1966-04-15 IL IL25595A patent/IL25595A/en unknown
- 1966-04-27 OA OA52430A patent/OA01951A/xx unknown
- 1966-05-06 BE BE680696A patent/BE680696A/xx unknown
- 1966-05-06 FR FR60670A patent/FR1592059A/fr not_active Expired
- 1966-05-06 CH CH659466A patent/CH478117A/de not_active IP Right Cessation
- 1966-05-07 NO NO162918A patent/NO123088B/no unknown
- 1966-05-09 GB GB20487/66A patent/GB1075420A/en not_active Expired
- 1966-05-09 PH PH7308A patent/PH10158A/en unknown
- 1966-08-05 FR FR72315A patent/FR5806M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1075420A (en) | 1967-07-12 |
| IL25595A (en) | 1971-01-28 |
| PH10158A (en) | 1976-09-13 |
| OA01951A (fr) | 1970-02-04 |
| FR5806M (cs) | 1968-02-19 |
| FR1592059A (cs) | 1970-05-11 |
| NO123088B (cs) | 1971-09-27 |
| CH478117A (de) | 1969-09-15 |